These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6407497)

  • 1. Review of the animal pharmacology and pharmacokinetics of fluvoxamine.
    Claassen V
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):349S-355S. PubMed ID: 6407497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaco-EEG profiles of antidepressants. Pharmacodynamic studies with fluvoxamine.
    Saletu B; Grünberger J; Rajna P
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):369S-383S. PubMed ID: 6407499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor.
    Claassen V; Davies JE; Hertting G; Placheta P
    Br J Pharmacol; 1977 Aug; 60(4):505-16. PubMed ID: 302726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluvoxamine as an antidepressant drug.
    Doogan DP
    Neuropharmacology; 1980 Dec; 19(12):1215-6. PubMed ID: 6777709
    [No Abstract]   [Full Text] [Related]  

  • 5. The antidepressant agents desipramine, fluoxetine, fluvoxamine and norzimelidine inhibit uptake of [3H]noradrenaline and [3H]5-hydroxytryptamine in slices of human and rat cortical brain tissue.
    Harms HH
    Brain Res; 1983 Sep; 275(1):99-104. PubMed ID: 6226337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
    Benfield P; Ward A
    Drugs; 1986 Oct; 32(4):313-34. PubMed ID: 3096686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluvoxamine: metabolic fate in animals.
    Ruijten HM; de Bree H; Borst AJ; de Lange N; Scherpenisse PM; Vincent WR; Post LC
    Drug Metab Dispos; 1984; 12(1):82-92. PubMed ID: 6141918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvoxamine, a new antidepressant drug, fails to show antiserotonin activity.
    Maj J; Rogóz Z; Skuza G
    Eur J Pharmacol; 1982 Jul; 81(2):287-92. PubMed ID: 6811291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluvoxamine influences serotonergic system in the brain: neurochemical evidence.
    Lapierre YD; Rastogi RB; Singhal RL
    Neuropsychobiology; 1983; 10(4):213-6. PubMed ID: 6427651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clovoxamine and fluvoxamine-2 biogenic amine re-uptake inhibiting antidepressants: quantitative EEG, psychometric and pharmacokinetic studies in man.
    Saletu B; Grünberger J; Rajna P; Karobath M
    J Neural Transm; 1980; 49(1-2):63-86. PubMed ID: 6777458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of antidepressants on aversive periaqueductal gray stimulation in rats.
    Jenck F; Broekkamp CL; Van Delft AM
    Eur J Pharmacol; 1990 Feb; 177(3):201-4. PubMed ID: 2107091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine.
    Nathan RS; Perel JM; Pollock BG; Kupfer DJ
    J Clin Psychiatry; 1990 Sep; 51(9):367-72. PubMed ID: 2120201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some central effects of repeated treatment with fluvoxamine.
    Maj J; Dereń A; Moryl E
    Pol J Pharmacol Pharm; 1989; 41(4):305-12. PubMed ID: 2576810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of acute and subchronic administration of various antidepressants on early morning melatonin plasma levels in healthy subjects: increases following fluvoxamine.
    Demisch K; Demisch L; Nickelsen T; Rieth R
    J Neural Transm; 1987; 68(3-4):257-70. PubMed ID: 3104537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the antidepressant binodaline on biogenic amine uptake and brain levels in the rat.
    Benfield DP; Luscombe DK
    Arzneimittelforschung; 1983; 33(6):847-50. PubMed ID: 6684438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tricyclic antidepessants on attack elicited by hypothalamic stimulation: relation to brain biogenic amines.
    Dubinsky B; Karpowicz JK; Goldberg ME
    J Pharmacol Exp Ther; 1973 Dec; 187(3):550-7. PubMed ID: 4272322
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological profile of binedaline, a new antidepressant drug.
    Morin D; Zini R; Urien S; Tillement JP
    J Pharmacol Exp Ther; 1989 Apr; 249(1):288-96. PubMed ID: 2540319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronopharmacological study of antidepressants in forced swimming test of mice.
    Ushijima K; Sakaguchi H; Sato Y; To H; Koyanagi S; Higuchi S; Ohdo S
    J Pharmacol Exp Ther; 2005 Nov; 315(2):764-70. PubMed ID: 16079297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of mianserin, a new antidepressant, on the in vitro and in vivo uptake of monoamines.
    Goodlet I; Mireylees SE; Sugrue MF
    Br J Pharmacol; 1977 Oct; 61(2):307-13. PubMed ID: 922259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressants and serotonin neurons of the raphe.
    Constantinidis J; Dick P; Tissot R
    Neuropsychobiology; 1981; 7(3):113-21. PubMed ID: 6785659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.